Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
Investor Relations
Stock Quote
Frequently Asked Questions
Press Kit
SEC Filings
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.


Corporate Presentation
Read the Nutra Pharma Corporate Presentation for essential information about the Company and its subsidiaries.

Download PDF (2.71mb)

Download PowerPoint (6.37mb)

Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.


Recent News
September 09, 2015
Nutra Pharma To Present at Upcoming Investment Conference

September 08, 2015
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration for the Treatment of Juvenile Multiple Sclerosis

July 15, 2015
Nutra Pharma Announces the Submission of Their First Orphan Drug Application to the US Food and Drug Administration (FDA)

Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
Facebook   Twitter
Privacy Policy Code of Ethics